Prednisone Oral Clinical Trials

• Prednisolone Pharmacokinetics in the Presence and Absence of Ritonavir After Oral Prednisone Administration to Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00072644 - Active, not recruiting
  Healthy
  
• Alternate Day Prednisone or Daily Fish Oil Supplements in Patients with Immunoglobulin A Nephropathy
  ClinicalTrials.gov Identifier: NCT00004448 - Active, not recruiting
  IGA Glomerulonephritis
  
• Phase II Study of Irofulven in Patients with Hormone-Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00124566 - Active, not recruiting
  Prostate Cancer
  
• CellCept® (Mycophenolate Mofetil) in Pemphigus Vulgaris
  ClinicalTrials.gov Identifier: NCT00140127 - Recruiting
  Pemphigus Vulgaris
  
• XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate Cancer (TROPIC)
  ClinicalTrials.gov Identifier: NCT00417079 - Recruiting
  Neoplasms; Prostatic Neoplasms
  
• Phase II Study of Revlimid®, Oral Cyclophosphamide and Prednisone for Patients With Newly Diagnosed Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00540644 - Recruiting
  Multiple Myeloma
  
• A Safety Analysis of Oral Prednisone as a Pre-Treatment for Rituximab in Rheumatoid Arthritis.
  ClinicalTrials.gov Identifier: NCT00580229 - Recruiting
  Rheumatoid Arthritis
  
• VELCADE/Melphalan/Prednisone Versus Melphalan/Prednisone in Patients with Previously Untreated Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00111319 - Active, not recruiting
  Multiple Myeloma
  
• Optical Sensor for Photodynamic Detection of Oral Pathology
  ClinicalTrials.gov Identifier: NCT00540774 - Enrolling by invitation
  Oral Diseaes; Abnormal Oral Mucosa
  
• Sudden Hearing Loss Multicenter Treatment Trial
  ClinicalTrials.gov Identifier: NCT00097448 - Recruiting
  Sudden Deafness
  
• Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00002653 - Active, not recruiting
  Multiple Myeloma
  
• GVAX® Prostate Cancer Vaccine vs Docetaxel and Prednisone in Patients with Metastatic Hormone-Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00089856 - Active, not recruiting
  Prostate Cancer
  
• The Effect of Preoperative Oral Prednisone on the Operative Field During Nasal Polypectomy: A Pilot Study
  ClinicalTrials.gov Identifier: NCT00440219 - Not yet recruiting
  Nasal Polyps
  
• AIRSAC Trial - Comparison of a Tacrolimus/Sirolimus/Prednisone Regimen Versus Tacrolimus/Azathioprine/Prednisone Immunosuppressive Regimen in Lung Transplantation
  ClinicalTrials.gov Identifier: NCT00321906 - Recruiting
  Delayed Graft Function; Graft Rejection
  
• High-dose Prednisone in Duchenne Muscular Dystrophy
  ClinicalTrials.gov Identifier: NCT00110669 - Active, not recruiting
  Duchenne Muscular Dystrophy
  
• Oral Health Education Program
  ClinicalTrials.gov Identifier: NCT00103493 - Active, not recruiting
  Dental Caries; Oral hygiene; Oral health; Dental health
  
• Pioglitazone in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
  ClinicalTrials.gov Identifier: NCT00099021 - Active, not recruiting
  lip and oral cavity cancer; Oropharyngeal Cancer; Oral Leukoplakia
  
• Phase I/II Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Elderly Patients with Advanced Stages Hodgkin''s Lymphoma
  ClinicalTrials.gov Identifier: NCT00147875 - Active, not recruiting
  Hodgkin''s Disease
  
• Docetaxel, Thalidomide, Prednisone, and Bevacizumab to Treat Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00089609 - Recruiting
  Prostatic Neoplasms
  
• Cyclophosphamide, Doxorubicin, Etoposide, and Prednisone OR Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Rituximab Followed by Vaccine Therapy Plus Sargramostim in Treating Patients With Stage II, Stage III, or Stage IV Follicular Lymphoma
  ClinicalTrials.gov Identifier: NCT00019981 - Recruiting
  Lymphoma
  
• Adjuvant Therapy for High Risk Prostate Carcinoma: A Phase III Randomized Study of Observation Vs. Deocetaxel and Prednisone
  ClinicalTrials.gov Identifier: NCT00132301 - Recruiting
  Prostate Cancer
  
• A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 2 Study Comparing AT-101 in Combination With Docetaxel and Prednisone Versus Docetaxel and Prednisone in Men With Chemotherapy-Naïve Metastatic Hormone Refractory Prostate Cancer (HRPC)
  ClinicalTrials.gov Identifier: NCT00571675 - Recruiting
  Hormone Refractory Prostate Cancer
  
• Fenretinide in Treating Patients with Neoplasia of the Mouth
  ClinicalTrials.gov Identifier: NCT00003223 - Active, not recruiting
  lip and oral cavity cancer; prevention of oral cancer
  
• Celecoxib in Treating Patients With Precancerous Lesions of the Mouth
  ClinicalTrials.gov Identifier: NCT00014404 - Active, not recruiting
  lip and oral cavity cancer; prevention of oral cancer
  
• Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma
  ClinicalTrials.gov Identifier: NCT00003283 - Active, not recruiting
  recurrent malignant thymoma; invasive malignant thymoma
  
• Wild Type p53 Adenovirus for Oral Premalignancies
  ClinicalTrials.gov Identifier: NCT00410865 - Active, not recruiting
  Mouth Cancer; Dysplasia/Carcinoma in Situ (CIS) of the Oral Cavity; Dysplasia/Carcinoma in Situ (CIS) of the Oral Pharynx
  
• Oral acyclovir for neonatal HSV disease of the skin,eyes and mouth
  ClinicalTrials.gov Identifier: NCT00031447 - Active, not recruiting
  Herpes Simplex
  
• Assessment of oral acyclovir in neonates with HSV involving the CNS
  ClinicalTrials.gov Identifier: NCT00031460 - Active, not recruiting
  Herpes Simplex
  
• Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx
  ClinicalTrials.gov Identifier: NCT00004234 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Nasopharyngeal Cancer; oral complications of cancer and cancer therapy; ...
  
• Docetaxel in Combination with GVAX ® Vaccine for Prostate Cancer Vs Docetaxel and Prednisone in Patients with Metastatic Hormone-Refractory Prostate Cancer With Pain
  ClinicalTrials.gov Identifier: NCT00133224 - Recruiting
  Prostate Cancer
  
• Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00151086 - Active, not recruiting
  Prostate Cancer
  
• Expression of Hypoxia-Inducible Factor-α in Oral Precancers and Cancers
  ClinicalTrials.gov Identifier: NCT00154973 - Recruiting
  Oral Cancer
  
• Prevention of Oral Malodor With an Oral Sticker Containing Herbal Formula
  ClinicalTrials.gov Identifier: NCT00250289 - Recruiting
  Halitosis; Oral Malodor; Bad Breath
  
• Lenalidomide and Prednisone in Treating Patients With Myelofibrosis
  ClinicalTrials.gov Identifier: NCT00227591 - Active, not recruiting
  Chronic Myeloproliferative Disorders
  
• The Prednisone-Sparing Effect of Anti-IL-5 Antibody (SB-240563)
  ClinicalTrials.gov Identifier: NCT00292877 - Active, not recruiting
  Asthma
  
• A study to assess the efficacy and safety of 100 mg and 150 mg monthly oral ibandronate in women with postmenopausal osteoporosis having completed the phase III oral ibandronate trial
  ClinicalTrials.gov Identifier: NCT00081653 - Active, not recruiting
  Osteoporosis
  
• Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00003584 - Active, not recruiting
  Stage IV Renal Cell Cancer; childhood kidney/urinary cancer; recurrent renal cell cancer
  
• A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
  ClinicalTrials.gov Identifier: NCT00323518 - Active, not recruiting
  Oral Mucositis; Stomatitis
  
• Safety of LBH589 Alone and in Combination With IV Docetaxel and Prednisone
  ClinicalTrials.gov Identifier: NCT00493766 - Active, not recruiting
  Hormone Refractory Prostate Cancer
  
• Smoking Status and Body Image in Oral Cancer Patients
  ClinicalTrials.gov Identifier: NCT00412490 - Active, not recruiting
  Oral Cavity Cancer
  
• Dentures and Dental Implants in Treating Patients Undergoing Surgery for Mouth Cancer
  ClinicalTrials.gov Identifier: NCT00006341 - Active, not recruiting
  oral complications of cancer and cancer therapy; stage III lip and oral cavity cancer; stage II lip and oral cavity cancer; Quality of Life; ...
  
• Phase II Randomized Study of Muromonab-CD3, Cyclosporine, Methylprednisolone, and Prednisone in Patients With Giant Cell Myocarditis
  ClinicalTrials.gov Identifier: NCT00004482 - Active, not recruiting
  Myocarditis; Giant Cell Myocarditis
  
• Laser Therapy in Preventing Oral Mucositis in Patients Undergoing Bone Marrow Transplantation
  ClinicalTrials.gov Identifier: NCT00024037 - Active, not recruiting
  oral complications of cancer and cancer therapy
  
• Surgery and Radiation Therapy With or Without Chemotherapy in Treating Patients With Mouth Cancer
  ClinicalTrials.gov Identifier: NCT00002747 - Active, not recruiting
  stage IV squamous cell carcinoma of the lip and oral cavity; stage II squamous cell carcinoma of the lip and oral cavity; ...
  
• Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00079261 - Active, not recruiting
  adult diffuse large cell lymphoma; adult lymphomatoid granulomatosis; anaplastic large cell lymphoma; angioimmunoblastic T-cell lymphoma; ...
  
• Hormone Therapy With or Without Mitoxantrone and Prednisone in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00004124 - Active, not recruiting
  adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; ...
  
• Diagnostic Trial in Patients Who Are Undergoing Surgery for Early Stage Mouth Cancer
  ClinicalTrials.gov Identifier: NCT00042926 - Active, not recruiting
  stage I squamous cell carcinoma of the lip and oral cavity; stage II squamous cell carcinoma of the lip and oral cavity
  
• Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003139 - Active, not recruiting
  oral complications of cancer and cancer therapy; oropharyngeal squamous cell carcinoma; lip and oral cavity squamous cell carcinoma
  
• Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation
  ClinicalTrials.gov Identifier: NCT00066469 - Recruiting
  post-transplant lymphoproliferative disorder
  
• Thalidomide, Prednisone, and Cyclophosphamide in Treating Patients With Myelofibrosis and Myeloid Metaplasia
  ClinicalTrials.gov Identifier: NCT00445900 - Active, not recruiting
  Chronic Myeloproliferative Disorders; Secondary Myelofibrosis
  
• Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00006890 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
  
• Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00022373 - Active, not recruiting
  Salivary Gland Cancer; lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients with Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00006051 - Active, not recruiting
  Throat Cancer; Oral Cancer
  
• Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat
  ClinicalTrials.gov Identifier: NCT00006994 - Active, not recruiting
  lip and oral cavity cancer; oral complications of chemotherapy and head and neck radiation; Oropharyngeal Cancer; Pain; radiation toxicity
  
• A Peri-Intubation Oral Intervention to Reduce Oral Flora and VAP
  ClinicalTrials.gov Identifier: NCT00248300 - Recruiting
  Pneumonia
  
• Effects of Oral Care in the Neuroscience ICU
  ClinicalTrials.gov Identifier: NCT00518752 - Recruiting
  Ventilator Associated Pneumonia; Oral Hygiene
  
• Fluorescence & Reflectance Imaging to Detect Oral Neoplasia
  ClinicalTrials.gov Identifier: NCT00542373 - Recruiting
  Oral Cancer
  
• Oral Budesonide vs. Oral Mesalazine in Active CD
  ClinicalTrials.gov Identifier: NCT00300118 - Recruiting
  Crohn's Disease
  
• Efficacy and Safety Study for an Oral Contraceptive Containing Folate
  ClinicalTrials.gov Identifier: NCT00468481 - Recruiting
  Oral Contraception
  
• Intraoral Grafting of Ex Vivo Produced Oral Mucosal Composites
  ClinicalTrials.gov Identifier: NCT00000111 - Active, not recruiting
  Mouth Diseases
  
• A Randomized Study of Sulindac in Oral Premalignant Lesions
  ClinicalTrials.gov Identifier: NCT00299195 - Recruiting
  Leukoplakia, Oral; Benign Neoplasms
  
• Fluorescence and Reflectance Spectroscopy for Diagnostic Assessment of Oral Mucosal Lesions
  ClinicalTrials.gov Identifier: NCT00507182 - Recruiting
  Oral Cancer
  
• Evaluation of a Multispectral Vision Enhancement System for Assessment of Oral Mucosal Lesions
  ClinicalTrials.gov Identifier: NCT00502580 - Recruiting
  Oral Cancer
  
• In Vivo Confocal Imaging of Oral Mucosa
  ClinicalTrials.gov Identifier: NCT00502125 - Recruiting
  Oral Tumors
  
• Efficacy of Elidel Cream on Erosive Oral Lichen Planus
  ClinicalTrials.gov Identifier: NCT00130572 - Recruiting
  Lichen Planus, Oral
  
• Changes in Oral Vitamin K Intake for Optimization of Chronic Oral Anticoagulation: A Randomized Trial
  ClinicalTrials.gov Identifier: NCT00355290 - Recruiting
  Blood Coagulation Disorders
  
• Fenretinide in Treating Patients With Leukoplakia of the Mouth
  ClinicalTrials.gov Identifier: NCT00004161 - Active, not recruiting
  prevention of oral cancer
  
• Study of Safety and Efficacy of a Basiliximab, Mycophenolate Mofetil, Cyclosporine Microemulsion and Prednisone Combination Treatment Regimen in Pediatric Renal Allograft Recipients
  ClinicalTrials.gov Identifier: NCT00228020 - Active, not recruiting
  Pediatric Kidney Transplantation
  
• Elective vs Therapeutic Neck Dissection in the Treatment of Early Node Negative Squamous Carcinoma of the Oral Cavity
  ClinicalTrials.gov Identifier: NCT00193765 - Recruiting
  Oral Cancer
  
• Oral Moxifloxacin Versus Cefazolin and Oral Probenecid in the Management of Skin and Soft Tissue Infections in the Emergency Department
  ClinicalTrials.gov Identifier: NCT00323219 - Recruiting
  Cellulitis
  
• Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC)
  ClinicalTrials.gov Identifier: NCT00450970 - Active, not recruiting
  Prostate Cancer
  
• UCN-01 and Prednisone in Treating Patients With Solid Tumors or Lymphoma
  ClinicalTrials.gov Identifier: NCT00045500 - Active, not recruiting
  Lymphoma; Unspecified Adult Solid Tumor, Protocol Specific
  
• A Study of NeoRecormon (Epoetin Beta), CellCept (Mycophenolate Mofetil) and Prednisone in Patients With Low or Intermediate Myelodysplastic Syndromes.
  ClinicalTrials.gov Identifier: NCT00551291 - Active, not recruiting
  Myelodysplastic Syndromes
  
• Bemiparin Randomized Trial on Bridging Oral Anticoagulants in Invasive Procedures (BERTA Study)
  ClinicalTrials.gov Identifier: NCT00484822 - Recruiting
  Long-Term Oral Anticoagulant Therapy
  
• Docetaxel and Prednisone With or Without OGX-011 in Treating Patients With Recurrent or Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00258388 - Active, not recruiting
  Prostate Cancer
  
• Calcitriol, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00182741 - Active, not recruiting
  Prostate Cancer
  
• Docetaxel, Prednisone, and Vatalanib in Treating Patients With Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00293371 - Active, not recruiting
  Prostate Cancer
  
• Velcade-Melphalan-Prednisone in Older Untreated Multiple Myeloma Patients.
  ClinicalTrials.gov Identifier: NCT00388635 - Active, not recruiting
  Multiple Myeloma
  
• CoQ10 and Prednisone in Non-Ambulatory DMD
  ClinicalTrials.gov Identifier: NCT00308113 - Recruiting
  Duchenne Muscular Dystrophy
  
• Thalidomide and Prednisone After Autologous Stem Cell Transplantation in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00049673 - Recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Patients With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00033293 - Recruiting
  localized resectable neuroblastoma; regional neuroblastoma; disseminated neuroblastoma; stage 4S neuroblastoma; localized unresectable neuroblastoma
  
• Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003327 - Active, not recruiting
  Nose Cancer; Oral Cancer
  
• The Role of SDF-1/CXCR4 in Metastasis of Oral Squamous Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00173849 - Not yet recruiting
  Oral Cancer
  
• Docetaxel and Prednisone With or Without Bevacizumab in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00110214 - Recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
  
• Safety and Immunogenicity of Oral Cholera Vaccine in Kolkata
  ClinicalTrials.gov Identifier: NCT00119197 - Active, not recruiting
  Cholera
  
• Prednisone and Either Cyclosporine or Tacrolimus With or Without Mycophenolate Mofetil in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease
  ClinicalTrials.gov Identifier: NCT00089141 - Recruiting
  Cancer; Graft Versus Host Disease
  
• Melphalan and Prednisone With or Without Bortezomib in Treating Older Patients With Newly Diagnosed Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00109902 - Recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Impact of Oral Ibandronate 150mg Monthly on Structural Properties of Bone in Postmenopausal Osteoporosis (SPIMOS-3D)
  ClinicalTrials.gov Identifier: NCT00271713 - Active, not recruiting
  Osteoporosis, Postmenopausal
  
• Prednisone Versus Tamoxifen in Idiopathic Retroperitoneal Fibrosis
  ClinicalTrials.gov Identifier: NCT00440349 - Active, not recruiting
  Retroperitoneal Fibrosis
  
• Biomarkers for Oral Cancer
  ClinicalTrials.gov Identifier: NCT00341497 - Active, not recruiting
  Oral Cancer
  
• Postoperative Radiotherapy According to Molecular Analysis of Surgical Margins of Oral and Oropharyngeal SCC
  ClinicalTrials.gov Identifier: NCT00232960 - Recruiting
  Oral Cancer; Oropharynx Cancer
  
• Enhancing Oral Health Care Use by HIV Positive Individuals
  ClinicalTrials.gov Identifier: NCT00444977 - Recruiting
  Oral Hygiene; HIV Infections; Mouth Diseases
  
• Docetaxel, Bevacizumab, Thalidomide, and Prednisone in Treating Patients With Metastatic Androgen-Independent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00091364 - Recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
  
• Efficacy and Safety of Oral Dehydroepiandrosterone as a Concomitant Therapy to Oral Contraceptives in Women Complaining of Reduced Libido
  ClinicalTrials.gov Identifier: NCT00566384 - Recruiting
  Decreased Libido
  
• UVB Phototherapy Treatment of Oral Chronic GVHD
  ClinicalTrials.gov Identifier: NCT00374257 - Recruiting
  Oral Chronic Graft-Versus-Host Disease
  
• Treatment of Oral Premalignant Lesions With 5-ALA PDT
  ClinicalTrials.gov Identifier: NCT00571974 - Recruiting
  Precancerous Lesions of the Oral Cavity; Leukoplakia; Erythroplakia
  
• RK-0202 in Preventing Oral Mucositis in Patients Who are Undergoing Radiation Therapy for Cancer of the Mouth, Throat, or Salivary Glands
  ClinicalTrials.gov Identifier: NCT00046956 - Recruiting
  lip and oral cavity cancer; Nasopharyngeal Cancer; oral complications of cancer and cancer therapy; Oropharyngeal Cancer; radiation toxicity; ...
  
• Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Oblimersen in Treating Patients With Advanced Diffuse Large B-Cell Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00080847 - Active, not recruiting
  contiguous stage II adult diffuse large cell lymphoma; noncontiguous stage II adult diffuse large cell lymphoma; ...
  
• A Phase II Trial to Assess the Effects of Green Tea in Oral Leukoplakia
  ClinicalTrials.gov Identifier: NCT00176566 - Recruiting
  Oral Leukoplakia
  
• The Effectiveness of Pasteurized Goat Milk in the Treatment of Childhood Oral Ulcer Diseases
  ClinicalTrials.gov Identifier: NCT00333749 - Recruiting
  Oral Ulcer